Your browser doesn't support javascript.

Biblioteca Virtual em Saúde


Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:


Adicionar mais destinatários
| |

Partial oral treatment of endocarditis.

Iversen, Kasper; Høst, Nis; Bruun, Niels Eske; Elming, Hanne; Pump, Bettina; Christensen, Jens Jørgen; Gill, Sabine; Rosenvinge, Flemming; Wiggers, Henrik; Fuursted, Kurt; Holst-Hansen, Claus; Korup, Eva; Schønheyder, Henrik Carl; Hassager, Christian; Høfsten, Dan; Larsen, Jannik Helweg; Moser, Claus; Ihlemann, Nikolaj; Bundgaard, Henning.
Am Heart J; 165(2): 116-22, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23351813


Guidelines for the treatment of left-sided infective endocarditis (IE) recommend 4 to 6 weeks of intravenous antibiotics. Conversion from intravenous to oral antibiotics in clinically stabilized patients could reduce the side effects associated with intravenous treatment and shorten the length of hospital stay. Evidence supporting partial oral therapy as an alternative to the routinely recommended continued parenteral therapy is scarce, although observational data suggest that this strategy may be safe and effective.


This is a noninferiority, multicenter, prospective, randomized, open-label study of partial oral treatment with antibiotics compared with full parenteral treatment in left-sided IE. Stable patients (n = 400) with streptococci, staphylococci, or enterococci infecting the mitral valve or the aortic valve will be included. After a minimum of 10 days of parenteral treatment, stable patients are randomized to oral therapy or unchanged parenteral therapy. Recommendations for oral treatment have been developed based on minimum inhibitory concentrations and pharmacokinetic calculations. Patients will be followed up for 6 months after completion of antibiotic therapy. The primary end point is a composition of all-cause mortality, unplanned cardiac surgery, embolic events, and relapse of positive blood cultures with the primary pathogen.


The Partial Oral Treatment of Endocarditis study tests the hypothesis that partial oral antibiotic treatment is as efficient and safe as parenteral therapy in left-sided IE. The trial is justified by a review of the literature, by pharmacokinetic calculations, and by our own experience.
Selo DaSilva